Review article · 2020 · Open access
Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
Diagnostics, 10(5), 326 · Published 20 May 2020 · DOI 10.3390/diagnostics10050326
In brief
“Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis” is a 2020 review article by Thuy Trang Nguyen and 4 co-authors, published in Diagnostics. OpenAlex counts 27 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Diagnostics.
- Citations
- 27
- Most cited in
- 2021 (5)
- Field-weighted impact
- 0.47
- References
- 139
- Authors
- 5
Abstract
Alzheimer's disease (AD) is a complex neurodegenerative disease that requires extremely specific biomarkers for its diagnosis. For current diagnostics capable of identifying AD, the development and validation of early stage biomarkers is a top research priority. Body-fluid biomarkers might closely reflect synaptic dysfunction in the brain and, thereby, could contribute to improving diagnostic accuracy and monitoring disease progression, and serve as markers for assessing the response to disease-modifying therapies at early onset. Here, we highlight current advances in the research on the capabilities of body-fluid biomarkers and their role in AD pathology. Then, we describe and discuss current applications of the potential biomarkers in clinical diagnostics in AD.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Nguyen, T. T., Ta, Q. T. H., Nguyen, T. K. O., Nguyen, T. K. O., & Van Giau, V. (2020). Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis. Diagnostics, 10(5), 326. https://doi.org/10.3390/diagnostics10050326
MLA 9
Nguyen, Thuy Trang, et al. “Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis.” Diagnostics, vol. 10, no. 5, 2020, p. 326. https://doi.org/10.3390/diagnostics10050326.
Chicago
Nguyen, Thuy Trang, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, Thi Kim Oanh Nguyen, and Vo Van Giau. 2020. “Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis.” Diagnostics 10 (5): 326. https://doi.org/10.3390/diagnostics10050326.
Harvard
Nguyen, T. T. et al. (2020) ‘Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis’, Diagnostics, 10(5), p. 326. doi:10.3390/diagnostics10050326.
IEEE
T. T. Nguyen, Q. T. H. Ta, T. K. O. Nguyen, T. K. O. Nguyen, and V. Van Giau, “Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis,” Diagnostics, vol. 10, no. 5, p. 326, 2020, doi: 10.3390/diagnostics10050326.
BibTeX
@article{nguyen2020role,
title = {{Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis}},
author = {Nguyen, Thuy Trang and Ta, Qui Thanh Hoai and Nguyen, Thi Kim Oanh and Nguyen, Thi Kim Oanh and Van Giau, Vo},
journal = {Diagnostics},
year = {2020},
volume = {10},
number = {5},
pages = {326},
doi = {10.3390/diagnostics10050326},
url = {https://doi.org/10.3390/diagnostics10050326}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 2 | |
| 2020 | 1 | |
| 2021 | 5 | |
| 2022 | 4 | |
| 2023 | 5 | |
| 2024 | 5 | |
| 2025 | 2 | |
| 2026 | 3 |
Its field-weighted citation impact is 0.47: it has been cited 0.47 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Alzheimer's disease
- body fluid biomarkers
- early diagnosis
- synaptic dysfunction
- disease-modifying therapy response
- disease progression monitoring
- clinical diagnostics
- biomarker validation
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Nguyen, T. T., Ta, Q. T. H., Nguyen, T. K. O., Nguyen, T. K. O., & Van Giau, V. (2020). Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis. Diagnostics, 10(5), 326. https://doi.org/10.3390/diagnostics10050326
How many times has this paper been cited?
27 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Diagnostics: sign in and open the PDF from this page.
Who wrote this paper?
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, Thi Kim Oanh Nguyen, Vo Van Giau.
What is the DOI of this paper?
10.3390/diagnostics10050326, permanently at https://doi.org/10.3390/diagnostics10050326. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.